Reimbursement

In Massachusetts, the expansion of the state's largest health system is offering a fractious case study of clinical integration and payment reform.

Are hospitals exploiting the 340B drug discount program? Critics of the federal government's program have some new evidence in the debate over healthcare subsidies.

A few months after opening its own primary care clinics, Walmart is expanding its insurance sales program, in what could be another step toward underwriting.

In the many quests for sound Medicaid reimbursement, healthcare provider advocates may soon have another tool to compel state governments.

Rural health providers may feel burdened by a confluence of policy and financing trends. But one opportunity, depending on the state, can help with sustainability.

Health plans, providers and legislators need to increase the number of primary care practitioners participating in Medicaid as the wait for many to access care is inadequate and getting worse as enrollment mushrooms.

Drug benefits stand as some of the most consequential consumer confusions that can arise in public exchanges, increasing the onus on insurers to improve the design and explanation of formularies.

CVS recently made the bold move of quitting tobacco as part of its retail health ambitions. Now, a chief rival is upping the bet, trying to target consumer incentives and enter a wellness market in flux.

Another health system is taking a step into insurance with Medicare Advantage, banking on seniors wanting access to a prestigious brand.

Medicare is fining a record number of hospitals -- 2,610 -- for having too many patients return within a month for additional treatments, federal records released Oct. 1 show. Thirty-nine of those are receiving the largest penalty allowed.